Locke Lord LLP
Methods related to the treatment of neurodegenerative and inflammatory conditions
The invention includes methods of neuroprotection, inducing release of neurotrophic factors, inhibiting the over-activation of innate immune cells, attenuating the toxin-induced death and/or damage of tissues, reducing inflammation, treating an inflammation-related condition, and inhibiting NADPH oxidase, that includes contacting or administering an effective amount of at least one compound of the invention that include: valproic acid, sodium butyrate, and salts thereof; opioid peptides; a peptide comprising the tripeptide GGF; and morphinans, such as naloxone, naltrexone, 3-hydroxy-morphinan and dextromethorphan.
The United States of America, as represented by the Secretary, Department of Health & Human Services
A A A A A A A A A A A A A A
A61P A61P A61K A61P A61K A61P A61P A61P A61P A61K A61K A61K A61P A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Po-See Guorong Liya Michelle Jau-Shyong Giia-Shuen Wei
Chen Li Qin Block Hong Peng Zhang